Scotia Capital’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-18,627
Closed -$775K – 928
2025
Q4
$775K Sell
18,627
-3,307
-15% -$134K ﹤0.01% 596
2025
Q3
$1.01M Buy
21,934
+6,878
+46% +$367K ﹤0.01% 562
2025
Q2
$796K Sell
15,056
-9,624
-39% -$508K ﹤0.01% 565
2025
Q1
$1.37M Sell
24,680
-1,868
-7% -$89.5K 0.01% 459
2024
Q4
$1.15M Buy
26,548
+5,912
+29% +$263K 0.01% 499
2024
Q3
$1.06M Buy
20,636
+9,341
+83% +$625K 0.01% 503
2024
Q2
$715K Buy
+11,295
New +$678K ﹤0.01% 544

Other funds holding CNXC

Scotia Capital's CNXC Position: Q1 2026 in Review

Scotia Capital sold out of Concentrix (CNXC) in Q1 2026, closing a stake of 18,627 shares — an estimated $775K sold.

Scotia Capital first reported a position in CNXC in Q2 2024 and held it in 7 quarters. The position peaked at $1.37M in Q1 2025. 304 funds tracked by Wall St. Rank hold CNXC as of Q1 2026.

  • Scotia Capital reported no remaining Concentrix position as of Q1 2026 after selling out during the quarter.
  • Scotia Capital sold 18,627 Concentrix shares in Q1 2026, an estimated $775K.
  • Scotia Capital first reported a position in Concentrix in Q2 2024 and held it in 7 quarters.
  • Scotia Capital's Concentrix position peaked at $1.37M in Q1 2025.
  • 304 funds tracked by Wall St. Rank held Concentrix as of Q1 2026.

Based on Scotia Capital's 13F filing for Q1 2026, filed 13 May 2026.